clal Yucel



* Departments of Biochemistry,
Ophthalmology, and
Pathology, Akdeniz University School of Medicine, Antalya 07070, Turkey;
Department of Pathology, Ankara University Medical School, Ankara 06100, Turkey; and || Human Gene Therapy Unit, Akdeniz Unversity School of Medicine, Antalya 07070, Turkey
1 Akdeniz University Medical School, Department of Biochemistry, 07070 Antalya, Turkey. E-mail: mutayaslan{at}akdeniz.edu.tr
| Abstract |
|---|
|
|
|---|
Keywords: uveitis, cornea, nitration, inducible nitric oxide synthase
| Introduction |
|---|
|
|
|---|
Nitric oxide (NO) is synthesized by a family of NO synthase (NOS) enzymes. Physiological amounts of NO synthesized by endothelial NOS (eNOS or NOS-3) and neuronal NOS (nNOS or NOS-1) participate in neuro-transmission and vascular signaling, whereas accelerated NO production by inducible NOS (iNOS or NOS-2) results in cytotoxicity (7). Previous studies in uveitic rats have reported the presence of NOS-2 immunoreactivity in vitreal inflammatory cells, the iris, the ciliary body, and inner retinal layers (5, 8). Similarly, intravitreal injection of LPS into rabbits resulted in NOS-2 expression in corneal fibroblasts and corneal epithelium (9). Accelerated NO production by NOS-2 results in cytotoxicity via direct reactions of NO and the formation of secondary species capable of oxidation and nitration reactions. Indeed, reduction of corneal edema is seen in uveitic rats after application of NG-nitro-L-arginine methyl ester, an NOS inhibitor (10).
The oxidation and nitration of lipids, amino acids, and proteins will alter biomolecular structure and function and at the same time reveal the pathogenic actions of reactive species (11). Corneal protein nitration has been observed in human corneal diseases such as keratoconus, Fuchs endothelial dystrophy, and in stored human corneal epithelium (12). Photoablated rabbit corneas have also revealed extensive protein nitration (9). This study aimed to examine corneal protein nitration in a rat model of EIU, which has not previously been investigated. Expression of NOS-2 and formation of NO was also studied in all experimental groups reported herein.
| Materials and Methods |
|---|
|
|
|---|
Ocular inflammation was induced via a single injection of intravitreal LPS as previously described (5). Briefly, LPS from Salmonella typhimurium (Sigma-Aldrich Chemie, Steinheim, Germany) was dissolved in sterile phosphate-buffered saline (PBS) at a concentration of 1 mg/ml. Rats were anesthetized intraperitoneally with a mixture of ketamine (25 mg/kg; Richter Pharma AG, Wels, Austria) and xylazine hydrochloride (5 mg/kg; Alfasan International B.V., Woerden, Holland), and 5 µg of LPS was injected into the vitreous of each eye. The controls received intravitreal injections of LPS-free PBS. Pain relief was provided to all rats via intramuscular (im) injections of tramadol hydrochloride (2 mg/kg; CONTRAMAL, Abdi Ibrahim, Istanbul, Turkey), given twice with 12-hr intervals, following intra-vitreal injections. Enucleation was performed 24 hrs after LPS injection in all experimental groups.
Immunohistochemical Staining.
Enucleated globe materials were fixed in 10% buffered formalin solutions and incised in transverse plane just from the center of the globe to obtain two equal parts. Fixed tissues were washed in PBS (pH 7.4), embedded in paraffin, and cut into 4-µm sections. For peroxidase staining, sections were deparaffined, rehydrated, and washed with Tris-buffered saline. Endogenous peroxidase activity was blocked by incubating tissue sections with 3% hydrogen peroxide for 5 mins prior to application of the primary antibody. Primary antibody incubations were at 25°C for 60 mins using rabbit polyclonal anti-NOS2 (1:100 dilution; Santa Cruz Biotechnology, Santa Cruz, CA) and anti-nitrotyrosine (anti-NO2Tyr; 10 µg/ml; Cayman Chemical, Ann Arbor, MI). After sections were washed they were immunostained with an avidin-biotin complex kit (Dako, Carpinteria, CA) followed by hematoxylin counterstaining. To assess non-specific staining for anti-NO2Tyr, control experiments were performed by preadsorbing anti-NO2Tyr with 10 mM NO2Tyr. Negative controls were also performed by replacing the primary antibody with nonimmune serum followed by immunoperoxidase staining. Presence of a red-brown–colored end product in the cytoplasm was indicative of positive staining. Counterstaining with hematoxylin resulted in a pale to dark blue coloration of cell nuclei.
To obtain a quantitative standard for polymorphonuclear cell infiltration within the different experimental groups, morphometric analysis was performed on all corneal sections by a pathologist blinded to the experimental conditions.
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) and Western Blot Analysis.
Cornea was harvested from enucleated globes and homogenized in 2 ml ice-cold homogenizing buffer (50mM K2HPO4, 80 µM leupeptin (Sigma-Aldrich, Steinheim, Germany), 2.1 mM Pefabloc SC (SERVA, Heidelberg, Germany), 1 mM phenylmethylsulfonyl fluoride (Sigma-Aldrich), 1µg/ml aprotinin (SERVA; pH 7.4). Homogenates were centrifuged (40,000 g, 30 mins, 4°C) and supernatants were stored at –80°C until analyzed. For Western blot analysis, tissue proteins were separated by SDS-PAGE and transferred to nitrocellulose membranes. A rabbit polyclonal antibody against anti-NO2Tyr (5 µg/ml; Cayman Chemical) and anti-NOS-2 (1:800 dilution; BD Transduction Laboratories, San Jose, CA) were used for immunoblot analysis. Horseradish peroxidase–conjugated goat anti-rabbit IgG (1:10,000 dilution; Zymed Laboratories, San Francisco, CA) was used as a secondary antibody, and immunoreactive proteins were visualized by chemiluminescence via ECL reagent (Amersham Pharmacia Biotech, Buckinghamshire, England). Proteins separated by SDS-PAGE were also visualized by Electro-Blue Staining solution (Qbiogene, Heidelberg, Germany).
Nitrite and Nitrate Assay.
Samples were transferred to an ultrafiltration unit and centrifuged through a 10-kDa molecular mass cut-off filter (Amicon, Millipore Corporation, Bedford, MA) for 1 hr to remove protein. Analyses were performed in duplicate via the Greiss reaction using a colorometric assay kit (Calbiochem, Darmstadt, Germany). Protein concentrations were measured at 595 nm by a modified Bradford assay using Coomassie Plus reagent with bovine serum albumin as a standard (Pierce Chemical Company, Rockford, IL).
| Results |
|---|
|
|
|---|
NOS-2 Expression.
LPS treatment caused a significant increase in NOS-2 protein expression, as determined by both Western blot analysis (n = 3) and immunohistochemical staining (n = 6). Figure 2A demonstrates the localization of NOS-2 in corneal cross sections in each of the two experimental groups. NOS-2–positive staining was observed in and around basal cells in the corneal epithelium. NOS-2 was not present in the cornea of control rats. Western blot analysis of corneal homogenates using an anti-NOS2 antibody also revealed a 130-kDa protein band present only in diseased rat groups (Fig. 2B).
NO2Tyr Formation.
The localization of protein NO2Tyr in corneal cross sections is demonstrated in Figure 3A. NO2Tyr-positive staining was observed in and around basal cells in the corneal epithelium. Protein nitration was present only in diseased rats and not in the controls. Corneal homogenates from all experimental groups were also analyzed by SDS-PAGE and visualized by both Western blot analysis using anti-NO2Tyr antibody and Coomassie blue staining for proteins. Western blot analysis of corneal homogenates using an anti-NO2Tyr antibody revealed multiple immunoreactive protein bands with molecular weights of 50 kDa or less (Fig. 3B). Comparison of the immunoreactivity pattern seen in the Western blots with protein staining showed that retinal proteins were not equally nitrated (Fig. 3C).
Nitrite and Nitrate Concentration.
Spectrophotometric measurement of total nitrate/nitrite levels in the vitreous affirmed significantly increased levels of nitric oxide generation in LPS-treated rats (126 ± 2.63 µM/mg protein) compared with controls (65 ± 6.57µM/mg protein). Values are mean ± SEM (n = 5–6). The statistical analysis of the obtained data was performed by Sigma Stat (version 2.03; Systat Software Inc., San Jose, CA) software for windows. The differences among the different groups were analyzed via the Students t test, with significance at P < 0.01 versus control.
| Discussion |
|---|
|
|
|---|
EIU can be created by injecting a single sublethal dose of bacterial LPS into the footpad or vitreus of an experimental animal. When LPS is injected into the footpad, uveitis occurs in both eyes, and the severity of inflammation can vary from animal to animal. Intravitreal injection of LPS increases reproducibility and causes a similar degree of ocular inflammation in all injected animals. Reported studies have documented that this method of EIU causes severe fibrinoid exudation in the papillary area, with intense flare in the anterior chamber at 24 hrs after injection (5). These symptoms compare to grade 4 (full score) uveitis(13); therefore, enucleation was performed 24 hrs after LPS injection.
Although uveitis is reported to involve mainly the anterior uvea and inner layers of the retina, the involvement of the cornea has also been suggested (10). As shown in Figure 1, extensive corneal PMN cell infiltration in uveitic rats was accompanied by stromal edema. This observation is in agreement with previous studies that report corneal ultrastructural pathology during EIU. Alterations in corneal endothelial and epithelial cells and corneal edema have been demonstrated during uveitis (10).
Corneal NOS-2 expression has been previously observed in rabbits treated with intravitreal LPS (9). In the reported study, NOS-2 was expressed in many inflammatory cells and fibroblasts in the corneal stroma. In this study, NOS-2–positive staining was mainly observed in and around basal cells in the corneal epithelium (Fig. 2). This observation is in accord with human studies that have identified NOS-2 staining in the epithelium of diseased corneas obtained from patients with bullous keratopathy, Fuchs dystrophy, and keratoconus corneas (12). The presence of NOS-2 in diseased corneas could be linked to the production of inflammatory cytokines that induce the expression of NOS-2. The cornea can be exposed to these cytokines either via the infiltrating PMN cells or by activated corneal cells (10). Indeed, tumor necrosis factor-
, which promotes NOS-2, is expressed in the cornea during the initial phase of inflammation (4). Similarly, interleukin-1β mRNA is induced in the cornea at a similar time course as that seen in the irisciliary body (14).
As seen in Figures 2 and 3A, the staining pattern for NOS-2 and NO2Tyr appear to correlate. That is to say, areas expressing NOS-2 corresponded to areas staining for NO2Tyr. Protein nitration observed during uveitis could be either via the formation of the oxidizing and nitrating species peroxynitrite (ONOO–) (15) or by peroxidase-catalyzed oxidation of nitrite (NO2–), an NO metabolite that is elevated in uveitis to the nitrating species nitrogen dioxide (NO2) (16). Myeloperoxidase (MPO), a heme peroxidase released during neutrophil, monocyte, and macrophage activation, can give rise to nitrotyrosine formation (11). As stated previously, LPS-induced changes in corneal cell ultrastructure initiate an inflammatory response which is causally linked to activation and adherence of neutrophils. It is well known that when neutrophils are activated by a proinflammatory signal the granules fuse with the plasma membrane in a simultaneous manner and discharge their contents into the extracellular medium (17). This process, also called degranulation, is a way by which MPO is released into sites of inflammation. The potential of MPO to diffuse away from areas of direct neutrophil infiltration and cause protein nitration was demonstrated using immunohistochemical techniques that illustrated the colocalization of MPO with areas of NO2Tyr formation (18).
NO2Tyr-positive staining observed in and around basal cells in the epithelium can lead to altered protein function within the cornea. A major function of corneal epithelium is to serve as a permeability barrier against the accumulation of fluid from the tear (19). In fact, studies have confirmed the existence of an NaK-ATPase (20) pump and an active Cl transport system (21) in the corneal epithelium that result in a net transfer of Na and Cl from the stroma to tears in the presence of a resting potential (22). Altered epithelial NaK-ATPase and Na-Cl pump activities can thus play a role in corneal edema observed in uveitis. In vitro reaction of 100–500 µM ONOO– with purified Na,K-ATPase has been shown to nitrate the 110-kDa alpha-3 catalytic and 50-kDa beta transport subunits, as quantified by immunoblots of the reaction products for NO2Tyr (22). Western blot analysis of corneal homogenates from uveitic rats using an anti-NO2Tyr antibody revealed an immunoreactive protein band with a molecular weight of 50 kDa (Fig. 3B) that may be speculated to function as a protein involved in epithelial ion transport.
In summary, immunohistochemical staining and Western blot analysis of the cornea revealed increased NOS-2 and nitrated protein immunoreactivity in uveitis. The presented data suggests that extensive formation of protein nitration in the cornea contributes to tissue destruction in uveitis. Hence, selective inhibition of NOS-2 may prevent long-term corneal complications and lead to an improvement in the management of uveitis.
|
|
|
|
| Footnotes |
|---|
Received for publication February 16, 2007. Accepted for publication July 9, 2007.
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||